RRC ID 89864
著者 Mensah EO, Nishimura K, Morishita K, Kato Y, Fukuda A, Sumaru K, Hisatake K, Sano M.
タイトル Enhancing the utility of Sendai virus-based vectors through antiviral compound-mediated removal.
ジャーナル J Biotechnol
Abstract Sendai virus (SeV)-based vectors are recognized as potential tools in gene therapy and regenerative medicine as they can express transgenes without chromosomal insertion. We previously reported that a replication-defective and persistent SeV (SeVdp) vector capable of long-term and multiple transgene expression can promote reprogramming of somatic cells into induced pluripotent stem (iPS) cells. Importantly, siRNA- and miRNA-mediated suppression of the SeV RNA-dependent RNA polymerase facilitates removal of SeVdp vectors from reprogrammed cells, resulting in establishing transgene-free iPS cells. However, these approaches are considerably dependent on transfection efficiency and intracellular miRNA activity, respectively. In this study, we assessed a simple approach to eliminate SeVdp vectors from infected cells using antiviral agents. GHP-88309, an antiviral compound against a broad range of paramyxoviruses, effectively inhibited SeV replication and enabled the removal of SeVdp vectors. Notably, this compound allowed complete elimination of a BRN4-expressing SeVdp vector from neural stem cells after enforced differentiation of embryonic stem cells. Our findings suggest that GHP-88309 would be an effective agent to enhance the utility and flexibility of SeVdp vectors in various biological and medical applications including transcription factor-mediated cell differentiation.
巻・号 414
ページ 176-185
公開日 2026-6-1
DOI 10.1016/j.jbiotec.2026.03.018
PII S0168-1656(26)00090-8
PMID 41856291
MeSH Animals Antiviral Agents* / pharmacology Cell Differentiation / drug effects Genetic Vectors* / genetics Humans Neural Stem Cells / cytology Sendai virus* / drug effects Sendai virus* / genetics Virus Replication / drug effects
リソース情報
ヒト・動物細胞 HCT116(RCB2979)